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Exons 5–15 of Kazrin Are Dispensable for Murine
Epidermal Morphogenesis and Homeostasis
Mariya K. Chhatriwala1,5, Sara Cipolat2,5, Lisa M. Sevilla3, Rachida Nachat4 and Fiona M. Watt1,2
Kazrin binds to periplakin and ARVCF catenin, and regulates adhesion and differentiation of cultured
human keratinocytes. To explore kazrin function in vivo, we generated a kazrin gene-trap mouse in which
only exons 1–4 were expressed, fused to b-galactosidase. On transient transfection, the protein encoded by
exons 1–4 did not enter the nucleus, but did cause keratinocyte shape changes. The mice had no
obvious defects in skin development or homeostasis, and periplakin and desmoplakin localization was
normal. Expression of the kazrin-b-galactosidase fusion protein faithfully reported endogenous kazrin
expression. Kazrin was not expressed in embryonic epidermis and was first detected at postnatal day 1. In
adult mice, epidermal kazrin expression was less widespread than in humans and Xenopus, being confined to
the bulb of anagen hair follicles, the infundibulum, and parakeratotic tail epidermis. In anagen bulbs, kazrin was
expressed by a band of cells with elongated morphology and low desmoplakin levels, suggesting a role in
morphogenetic cell movements. We conclude that exons 5–15 of kazrin, encoding the nuclear localization
signal and C-terminal domain, are not required for epidermal development and function. The previously
reported role of kazrin in regulating cell shape appears to reside within the N-terminal coiled-coil domain
encoded by exons 1–4.
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INTRODUCTION
Kazrin is an evolutionarily conserved cytoplasmic and nuclear
protein that was originally identified as a binding partner of
periplakin, a component of epidermal desmosomes and the
cornified envelope (Groot et al., 2004). Five isoforms of kazrin
have been described. The four short isoforms encode three
proteins (kazrinA, B, and C/D) that have different N termini, but
all contain a coiled-coiled domain responsible for binding
periplakin, and a putative nuclear localization signal (NLS)
(Groot et al., 2004; Wang et al., 2009). The short isoforms of
kazrin have no known homologs. The long isoform, kazrinE,
possesses additional 30 exons that encode a C-terminal liprin
homology domain that can associate with the leukocyte
common antigen–related protein tyrosine phosphatase (Nachat
et al., 2009).
Overexpression of kazrinA stimulates terminal differentiation
of cultured human keratinocytes and is associated with a
reduction in F-actin content, disruption of desmosome
assembly, and changes in cell shape. Overexpression of
activated RhoA rescues the effects on cell shape and
adhesion. Conversely, knockdown of kazrinA impairs term-
inal differentiation, but does so independently of RhoA
activity (Sevilla et al., 2008a). Overexpression of kazrinE also
results in terminal differentiation of human keratinocytes and
changes in cell shape. In addition, kazrinE colocalizes with
stabilized microtubules in differentiating keratinocytes
(Nachat et al., 2009). All kazrin isoforms can form complexes
with one another (Nachat et al., 2009), raising the possibility
that, together with periplakin and envoplakin, kazrin forms a
cortical scaffold that integrates the actin cytoskeleton with
desmosomes (Ruhrberg et al., 1997; Kalinin et al., 2001;
Groot et al., 2004).
Studies of kazrin function in vivo have been limited to
Xenopus embryos, where depletion of endogenous kazrin
results in striking defects in axial elongation, muscle and
notochord differentiation, and epidermal morphogenesis.
These effects are believed to be due to the disruption
in the formation of cell–cell junctions (Sevilla et al., 2008b;
Cho et al., 2010). Given the effects of modulating kazrin levels
in cultured keratinocytes and in Xenopus embryos, we
hypothesized that knocking out kazrin in mice would result
in a severe epidermal phenotype. In this study, we have
examined the phenotype of two independent lines of mice in
which only the first four exons of kazrin are expressed.
& 2012 The Society for Investigative Dermatology www.jidonline.org 1977
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RESULTS
Generation of mice lacking exons 5–15 of kazrin
Two different strategies were used to knock out kazrin, which
made use of targeted embryonic stem (ES) cells available via
SIGTR. In the first strategy, a gene trap consisting of b-
galactosidase fused to a neomycin resistance gene (b-geo)
was inserted between exons 4 and 5 of the murine kazrin
gene (Figure 1a). Mice homozygous for the gene trap (gt/gt)
expressed exons 1–4 of kazrin fused to b-geo (Figure 1b)
instead of wild-type (wt) kazrin. To confirm that any observed
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Figure 1. Generation of kazrin b-galactosidase (b-gal) gene-trap (gt/gt) mouse and conditional knockout (flx/flx) mice. (a) Exon structure of mouse kazrin.
Blue box represents insertion of the neomycin resistance gene (b-geo) cassette in the kazrin b-gal gt/gt mouse. Red triangles indicate loxP sites for removing exon
5 in the kazrin flx/flx mice. (b) Predicted domain architecture of kazrin-b-geo fusion protein in the kazrin b-gal (top) gt/gt mouse and kazrin fragment expressed in
the (bottom) kazrin flx/flx mouse. (c) RT-PCR amplification of transcripts upstream (exons 2–3) or downstream (exons 4–5) of the gene trap. RNA in each
lane is from a single representative litter-matched mouse of the genotype indicated. (d) Quantitative RT-PCR of transcripts upstream (exons 2–3) and downstream
(exons 6–7) of the gene trap. Top: Expression values relative to glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Each bar shows the mean and standard
deviation of at least three mice per genotype. Bottom: Ratio (%) of upstream and downstream transcripts from the top panel. Primer positions upstream
and downstream of the b-geo cassette are indicated by the orange and green brackets, respectively, in a. (e) Alignment of predicted amino-acid sequences
encoded by exons 1 and 2 of human kazrinA and mouse kazrin. (f) RT-PCR amplification of exons 1–4, 1–5, 2–4, or 2–5 of mouse kazrinA. Positive (GAPDH) and
negative (water) controls are shown. b-geo, b-galactosidase fused to a neomycin resistance gene; Ex, exon.
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phenotypic effects were due to deletion of exons 5–15 and
not due to the expression of the b-geo cassette, we used a
second strategy whereby exon 5 of kazrin was flanked by
loxP sites. Mice with the targeted gene were crossed with
PGK-Cre mice; as a result, only exons 1–4 of kazrin were
expressed (conditional knockout, flx/flx) in all tissues (Figure
1b). The gt/gt and flx/flx mice were born in normal Mendelian
ratios, were fertile, and did not show any gross phenotypic
abnormalities.
To confirm targeting of kazrin, we amplified kazrin mRNA
using primers designed to amplify exons 2–3, 4–5, or 6–7
(Figure 1a, c, and d). Exons 2–3 were expressed at similar
levels in wt, gt/gt, and flx/flx mice, as well as in heterozygous
animals (wt/gt, wt/flx), when assessed by semiquantitative RT-
PCR (Figure 1c) or quantitative RT-PCR (Figure 1d). In con-
trast, the levels of exons 4–5 (Figure 1c) and 6–7 (Figure 1d)
were reduced in heterozygous mice and virtually undetect-
able in homozygous mice.
A comparison of the predicted protein sequences of
human and mouse kazrin (as published on the USCS Genome
Browser; http://genome.ucsc.edu/) revealed that the proteins
encoded by exons 2–8 of mouse (accession number
NP_001103155.1) and human (accession number
NP_056024.1) kazrinA are over 90% identical, but there is
significant divergence in exon 1 (Figure 1e). In contrast, exon
1 of mouse kazrinE is predicted to be identical to human
kazrinA exon 1 (Okazaki et al., 2004; Diez-Roux et al.,
2011). By using primers specific for exon 5 and for each
predicted form of mouse exon 1 in mouse skin, we were able
to amplify a kazrin fragment with the primer to the divergent
exon 1 (Figure 1e), but not to the homolog of human kazrinA
exon 1 (Figure 1f and data not shown). By using primer pairs
for mouse exons 1 and 4, 2 and 4, 1 and 5, or 2 and 5, we
amplified a single band (Figure 1f). Therefore, we did not
obtain evidence for alternative splicing between exons 1 and
5 of mouse kazrin.
Generation of antibodies to recombinant kazrin
The antibodies we previously generated to kazrin were raised
against peptides corresponding to different domains and
splice variants of the protein (Groot et al., 2004; Sevilla et al.,
2008a; Nachat et al., 2009). To generate a pan-kazrin
antibody and maximize the number of binding sites available
for antibody recognition, we overexpressed full-length
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Figure 2. Analysis of kazrin protein expression. (a) Domain architecture of kazrinA and kazrinE. The N terminus of kazrinE is identical to kazrinA.
(b) Purification of recombinant human kazrinA overexpressed in Escherichia coli as a glutathione-S-transferase (GST) fusion protein. (c) Lysates of normal human
keratinocytes transfected with scrambled small interfering RNA (siControl) or pooled siRNAs specific for all isoforms of kazrin (siKazrinAll) were blotted
with pan-kazrin antibody, rabbit pre-immune serum, or rabbit secondary antibody alone. (d) Pan-kazrin antibody crosslinked to protein G agarose beads was
used to immunoprecipitate endogenous kazrin from lysates of normal human keratinocytes. (e, f) Pan-kazrin antibody detection of endogenous kazrin, kazrin
b-galactosidase (b-gal) fusion protein, and the 28-kDa fragment encoded by kazrin exons 1–4 in lysates of wild-type (wt) mice or litter-matched gene trap
(gt/gt) and conditional knockout (flx/flx) mice. simKazrinAll: wt/wt keratinocytes transfected with two pooled siRNAs (see also Supplementary Figure S1c online).
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a loading control for c–f.
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human kazrinA as a glutathione-S-transferase (GST) fusion
protein in Escherichia coli. The GST tag was cleaved after the
initial purification. KazrinA was further purified over a size-
exclusion column before being used to immunize rabbits
(Figure 2a and b). KazrinA has a predicted molecular mass of
47 kDa, but runs approximately 5–6 kDa higher on poly-
acrylamide gels (Groot et al., 2004; Sevilla et al., 2008a;
Nachat et al., 2009) (Figure 2b).
To determine whether the new antibody recognized
endogenous kazrin, we immunoblotted lysates of primary
human keratinocytes that had been transfected with either
control small interfering RNA (siRNA) or a siRNA to all
isoforms of kazrin (Figure 2c and Supplementary Figure S1a
online). The antibody recognized bands with molecular
masses corresponding to kazrin isoforms A, B, C/D, and E,
which were reduced in abundance by kazrin siRNA
transfection. The antibody also immunoprecipitated kazrin
from lysates of primary human keratinocytes (Figure 2d). The
kazrinA band detected with the antibody to recombinant
kazrin had the same mobility as that detected with a
commercial kazrin antibody and the pan-kazrin LS7 antibody
we described previously (Sevilla et al., 2008a; Supplementary
Figure S1b online).
To test whether the new pan-kazrin antibody recognized
mouse kazrin, we performed immunoblotting on lysates of
keratinocytes cultured from wt/wt, gt/gt, wt/flx, and flx/flx
mice, as well as wt/wt keratinocytes in which kazrin had
been knocked down (Figure 2e and Supplementary Figure
S1c and d online). The antibody recognized a band of
approximately 180 kDa, corresponding to the kazrin b-
galactosidase fusion protein in gt/gt cells, and detected
endogenous short kazrin isoforms in wt/wt mice. In human
keratinocytes, kazrinE is considerably less abundant than
kazrinA (Figure 2c), and in mouse keratinocytes kazrinE
protein was undetectable (Figure 2e). Lysates of primary
keratinocytes cultured from adult kazrin flx/flx mice had no
detectable full-length kazrin; however, on long exposures of
the blots, a 28-kDa band, predicted to correspond to kazrin
exons 1–4, was present in flx/flx and wt/flx cells, but not in
wt/wt cells (Figure 2f).
We conclude that the antiserum generated against
recombinant human kazrin detects all human kazrin isoforms
and crossreacts with mouse kazrin. By probing blots of
keratinocytes from the gt/gt and flx/flx mice, we confirmed
successful deletion of full-length kazrin and expression
of the N-terminal region encoded by exons 1–4, either as a
b-galactosidase fusion protein (Figure 2e) or as a 28-kDa
fragment (Figure 2f).
Functional analysis of kazrin exons 1–4
Several studies have shown that full-length kazrin can
localize to the nucleus in the epidermis and cultured
cells (Groot et al., 2004; Sevilla et al., 2008a; Cho et al.,
2010), and mutation of key lysine residues in the NLS of
Xenopus kazrin prevents nuclear accumulation (Cho et al.,
2010). The fragment of kazrin expressed in the gt/gt and
flx/flx mice (exons 1–4) encompasses the majority
of the coiled-coil domain, but lacks the NLS (Figures 1a
and 2a).
To determine whether the protein encoded by exons 1–4
could nevertheless enter the nucleus, and whether or not it
induced cell shape changes, a plasmid encoding exons 1–4
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Figure 3. Transient expression of full-length kazrin or exons 1–4 in
cultured human keratinocytes. (a–e) Immunolabeling of kazrin (green)
with 40,6-diamidino-2-phenylindole (DAPI) nuclear counterstain (blue).
(f) Quantification of effect of kazrin exons 1–4 on cell morphology. Cells
were scored as having altered cell shape (elongation/prominent filopodia/
prominent lamellipodia), cytoplasmic kazrin puncta, or both. Data are
mean±SEM of three experiments. The numbers of cells scored per
experiment were 128, 245, or 180. Bars¼ 25 mm. Ex, exon.
Figure 4. Comparison of skin of wild-type (wt/wt) and kazrin gene trap (gt/gt) and conditional knockout (flx/flx) mice. Sections of adult back (anagen or
telogen) and tail skin from litter-matched wt/wt, gt/gt, or flx/flx mice were (a, b) stained with hematoxylin and eosin or (c, d) labeled with antibodies to Ki67, (e, f)
desmoplakin, or (e, f) periplakin. Bars: 100mm in all panels.
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was overexpressed in cultured human keratinocytes by
transient transfection (Figure 3). As reported previously, full-
length kazrinA localized to the cytoplasm and, in some cells,
also to the nucleus, and caused characteristic changes in cell
shape (Figure 3a and b) (Groot et al., 2004; Sevilla et al.,
2008a, b). The N-terminal fragment of kazrin, encoded by
exons 1–4, did not accumulate in the nucleus, consistent
with the lack of an NLS (Figure 3c). Nevertheless, it did
cause the same changes in cell shape as full-length
kazrinA, with cells forming lamellipodia and filopodia
and frequently becoming elongated (Figure 3d and e).
The N-terminal coiled-coil domain also accumulated
frequently in puncta throughout the cytoplasm (Figure 3e).
Almost 60% of cells that overexpressed the N terminus of
kazrinA exhibited morphological changes (Figure 3f) ( Sevilla
et al., 2008a, b).
We conclude that the ability of kazrin to regulate
keratinocyte morphology resides within exons 1–4 of the
protein.
Epidermal phenotype of mice lacking kazrin exons 5–15
Mice lacking full-length kazrin had grossly normal skin
and a normal hair growth cycle (data not shown).
H&E-stained sections of the back and tail skin of adult wt/
wt, gt/gt, and flx/flx mice did not reveal any differences in
overall morphology, irrespective of whether they were
examined in telogen or anagen (Figure 4a and b). There
were no changes in the cornified layers (Figure 4a and b),
and no differences in epidermal proliferation as assessed by
Ki67 staining (Figure 4c and d).
As kazrin binds periplakin (Groot et al., 2004) and kazrin
overexpression interferes with desmosome assembly (Sevilla
et al., 2008a; Nachat et al., 2009), we investigated whether
the distribution of periplakin and desmoplakin was affected by
the absence of full-length kazrin. We found that expression of
desmoplakin and periplakin in both the interfollicular
epidermis (IFE) and hair follicles was normal, with both
proteins still localizing to cell–cell borders in the epidermis
(Figure 4e and f and Supplementary Figure S2 online).
E17.5 back skin
P1 tail
P5 tail P10 tail
P3 back skin P3 tail
E17.5 tail P1 back skin
P10 tail—infundibulum
Figure 5. b-Galactosidase expression in the epidermis of gene-trap mice. Epidermal whole mounts of back (a, c, e) and tail (b, d, f–i) from the ages indicated
were stained for X-gal. Bars: 200mm in all panels. E17.5, embryonic day 17.5; P1, postnatal day 1.
Figure 6. Kazrin expression in adult mice. (a) Epidermal tail whole mount of kazrin gene-trap (gt/gt) mouse stained for X-gal to visualize endogenous kazrin in
hair during anagen. Inf, infundibulum; IRS, inner root sheath. (b) Quantitative RT-PCR of mRNA from anagen back skin, telogen back skin, or telogen tail skin
using primers to detect all forms of kazrin (exons 6 and 7) or specific for kazrinE (KazE) (exons 10 and 11). The unpaired Student’s t-test was used to determine
whether differences in transcript levels were statistically significant. (c–e) Paraffin sections of tail-scale interfollicular epidermis from kazrin gt/gt mouse co-
stained with antibodies to (c, d; red) K14 and (c, e; green) kazrin or (d; green) non-immune serum with (blue) 40,6-diamidino-2-phenylindole (DAPI) nuclear
counterstain. Field shown in (e) partially overlaps with the field shown in c. (f, g) Frozen section of tail skin from kazrin gt/gt mice stained for (blue) X-gal and
counterstained (with nuclear fast red). (g) Higher-magnification view of the area demarcated by the black box in f. (h–t) Tail epidermal whole mounts stained
with (h) non-immune serum, or the antibodies indicated. (j) Higher-magnification view of the area demarcated with white dashed line in i. (c–e, h–n) Blue
staining is the DAPI nuclear counterstain. (j–t) The epidermis from wt/wt mice, except (l), which is from gt/gt mouse. Bars: (a, c, d, f, j–r) 100 mm; (e) 40 mm; (h, i)
200mm; and (s, t) 50 mm.
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Kazrin expression during epidermal morphogenesis
We next exploited the gt/gt mice to examine kazrin
expression during epidermal morphogenesis. We harvested
the epidermis from mice at various developmental stages and
performed whole-mount X-gal staining to examine b-galac-
tosidase expression (Figure 5). Kazrin was not expressed in
the epidermis before postnatal day 1 (P1) (Figure 5a and b). At
P1, b-galactosidase activity was present in developing hair
follicles in both back and tail skin (Figure 5c and d). b-
galactosidase activity increased in the hair follicles between
P1 and P5, as the follicles continued to develop (Figure 5e–g).
By P10, when the follicles were synchronously in anagen, b-
galactosidase activity was also detectable in the hair follicle
infundibulum and in the parakeratotic interfollicular epider-
mal scales of the tail (Figure 5h and i).
Kazrin expression in the adult epidermis
Using whole mounts of tail epidermis, we examined b-
galactosidase activity in gt/gt mice at different phases of the
adult hair growth cycle (Figure 6a and Supplementary
Figure S3 online). b-Galactosidase was detected in the hair
follicle infundibulum and IFE of the scales at all stages of the
hair cycle and in the bulb of anagen follicles. In addition, we
detected kazrin in the inner root sheath at all stages of the
hair cycle except for telogen. There was no b-galactosidase
activity in the sebaceous glands and non-scale IFE (Figure 6a
and Supplementary Figure S3 online).
Levels of endogenous kazrin mRNA in wt/wt mice were
measured by quantitative RT-PCR using probes that detected all
forms of kazrin or were specific for kazrinE (Figure 6b). As
expected from the whole-mount analysis (Figure 6a), levels of
kazrin mRNA in the back skin were higher in anagen than in
telogen. Kazrin mRNA levels were higher in telogen tail
than in anagen back skin, probably reflecting kazrin
expression in the interfollicular epidermis of tail but not
in back skin. Levels of kazrinE mRNA were considerably
lower than levels of total kazrin (Figure 6b), as predicted
from the western blots (Figure 2).
To examine kazrin expression at greater resolution, we
compared b-galactosidase expression in gt/gt skin with
expression of the endogenous protein in wt/wt skin. We
stained sections of gt/gt tail skin for b-galactosidase and
sections of wt/wt skin with anti-kazrin antiserum (Figure
6c–g). As observed by whole-mount labeling (Figure 5h and
i), the expression of b-galactosidase in tail IFE from P10
onward was restricted to the scales, hair follicle bulb, and
inner root sheath. This was in good agreement with antibody
labeling of tail skin sections (Figure 6c and e). In tail scales,
kazrin was weakly expressed in the basal epidermal layer and
upregulated in the suprabasal layers (Figure 6c–g).
When whole mounts of wt/wt adult tail epidermis were
labeled with the pan-kazrin antibody, the staining pattern
was as predicted from the b-galactosidase staining, with
labeling of the infundibulum, IFE scale, and anagen bulb
(Figure 6h–j). Staining of the hair follicle bulge was non-
specific because it was also observed with non-immune
serum (Figure 6h). Confocal cross-sections through anagen
follicles revealed that kazrin was also expressed in the
inner root sheath, again as observed in the reporter mice
(Figure 6m and n).
Previous work has shown that overexpression of kazrin
results in marked changes in cell shape, with cells becoming
elongated (Sevilla et al., 2008a; Figure 3). Co-staining for
kazrin and E-cadherin (Figure 6o and p) or desmoplakin
(Figure 6q–t) revealed strong expression of kazrin in elongated
cells of the upper anagen bulb that exhibited relatively
low levels of E-cadherin and desmoplakin. These cells
comprise a differentiating population of keratinocytes
(Tumbar et al., 2004; Schneider et al., 2009). However,
in spite of the inverse correlation between kazrin and
desmoplakin in these cells, their number, morphology, and
location were unaffected by deletion of kazrin exons 5–15
(Figure 6k and l).
DISCUSSION
In this report, we have generated two mouse lines, a b-
galactosidase gene trap and a conditional knockout, which
only express the first four exons of kazrin, and pan-kazrin
antibodies to study kazrin expression and function. Using
these, we show that in mouse epidermis kazrin has a more
restricted distribution than in human and Xenopus (Groot
et al., 2004; Sevilla et al., 2008a), and that exons 5–15 are
dispensable for normal epidermal development and homeo-
stasis. By overexpressing exons 1–4 in cultured keratinocytes,
we show that the N terminus and coiled-coil domain of
kazrin are responsible for inducing the changes in cell shape
observed on overexpression of full-length kazrin (Sevilla
et al., 2008a).
In murine epidermis, kazrin expression was first detectable
in developing hair follicles at P1. From P10 onward, it was
expressed in the bulb of anagen follicles, the infundibulum of
all follicles, and in the parakeratotic epidermal scales of the
tail. In addition, kazrin was expressed in the inner root
sheath of anagen and catagen follicles. We did not detect
kazrin in the interfollicular epidermis of mouse back skin.
However, in mouse tail, as in human (Groot et al., 2004;
Sevilla et al., 2008a) interfollicular epidermis, kazrin expres-
sion was upregulated in the differentiating, suprabasal layers
of keratinocytes.
Both strains of mice lacking kazrin exons 5–15 were
phenotypically normal. Deletion of these exons eliminates
translation of the NLS sequence (Figure 2a), and also kazrinE
(Nachat et al., 2009). As we confirmed that the region of kazrin
encoded by the first four exons does not enter the nucleus
(Figure 3c), we conclude that kazrin function is independent of
nuclear localization. The lack of any phenotype resulting from
the deletion of kazrinE is not surprising given our inability to
detect significant levels of endogenous kazrinE mRNA (Figure
6b) or protein (Figure 2e). Although we could detect kazrinE
protein in lysates of cultured human keratinocytes, the level
was significantly lower than that for the short kazrin isoforms
(Figure 2c). We conclude that the C-terminal liprin homology
domain of kazrinE, which binds leukocyte common antigen–-
related and acetylated microtubules, is not required for mouse
epidermal development and homeostasis (Sevilla et al., 2008a;
Nachat et al., 2009).
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There are several potential explanations for the lack of a
phenotype in the kazrin gt/gt and flx/flx mice. One is that it
reflects the different sites of kazrin expression in the
epidermis from different species (humans, Xenopus, and
mice). Another is that there are compensatory mechanisms
that operate in the mouse that are not evident in other species
or when cells are placed in culture. This would be surprising,
given that kazrin is evolutionarily highly conserved; that the
short isoforms have no known homologs that would be
obvious candidates for functionally redundant proteins; and
that kazrin knockdown in cultured keratinocytes stimulates
proliferation and inhibits terminal differentiation (Sevilla
et al., 2008a). A third possibility, and one that we favor,
given that the expression of exons 1–4 can induce keratino-
cyte shape changes in culture, is that the functions of kazrin
are mediated by the portion of the coiled-coil domain that is
encoded by exons 1–4. Coiled-coil domains are well known
for their ability to mediate protein–protein interactions
(McFarlane et al., 2009), and the kazrin coiled-coil domain
binds periplakin (Groot et al., 2004), the p120 subfamily
catenin ARVCF, and p190B RhoGAP (Cho et al., 2010). As
kazrin lacks any obvious enzymatic function, it is attractive to
speculate that its main function is to recruit proteins through
the coiled-coil domain. It will therefore be of interest to
perform further analysis of kazrin-interacting partners and to
delete kazrin exons 1–4 in mice.
MATERIALS AND METHODS
Generation of mice lacking exons 5–15 of kazrin
All experiments were carried out under the terms of a UK
government Home Office project license, with local ethics approval
from the CRUK Cambridge Research Institute. Kazrin b-gal gene-trap
reporter mice (gt/gt) were generated from ES cells (clone AN0881;
129SvEv strain) carrying a mutant Kazrin locus. ES cells were
generated by random insertional mutagenesis with the pGT0lxr-bgeo
gene-trap vector containing intronic sequences and a splice acceptor
site from the engrailed-2 gene, the LacZ coding sequence, and a
neomycin-resistance cassette for selection (Wellcome Trust Sanger
Institute Gene Trap Resource, Cambridge, UK). ES cells were
injected into C57BL/6 mouse blastocysts to generate germline
chimeras. Chimeric mice were mated with F1 mice and offspring
heterozygous for the gene-trap insertion (Kazrinþ /gt) were inter-
crossed to generate homozygotes (Kazringt/gt). Mice were maintained
in an F1 genetic background (C57BL6/CBA).
As the second strategy to delete kazrin, two conditional knockout
ES clones (C57Bl/6N strain) obtained from SIGTR (9030409G11Rik,
see SIGTR for construct detail) were injected into eight-cell embryos
(CD1). Germline transmission was achieved from both clones by
crossing with C57Bl6 females, but long-range PCR and sequence
analysis showed that the LacZ coding sequence in the gene-targeting
cassette contained a deletion in both ES clones. Therefore, we
generated a flx/flx mouse. Heterozygous mice derived from one of
the two ES clones were mated with 129S4/SvJaeSorGt(ROSA)
26Sortm1(FLP1)Dym/JJAX mice (C57BL/6J; Jackson laboratory,
Bar Harbor, ME) to remove the FRT-En2-IRES-BGal-loxP-Neo-pA
cassette, and then crossed with pGK-Cre-expressing mice
(Lallemand et al., 1998) to generate kazrin exon 5–deleted mice
(Kazrinwt/flx). Mice homozygous for deletion of exon 5 were
generated by crossing heterozygous mice and maintained in a
C57BL/6J genetic background.
Kazrin protein purification
Full-length human kazrinA was cloned into the pGEX-6p1 (GE
Healthcare, Chalfont St Giles, UK) vector for expression with an
N-terminal GST tag and overexpressed in the BL21 (DE3) E. coli
strain. Transformed cells were grown in LB medium containing
0.1mgml1 of ampicillin at 37 1C to an A600 of 0.7 (mid-log phase)
and induced with 0.1mM isopropyl-b-D-thiogalactopyranoside at
18 1C for 18 hours. Harvested cells were resuspended in buffer A
(2mM dithiothreitol, 20mM Tris, pH 7.5, 200mM NaCl, 5% glycerol)
supplemented with EDTA-free protease inhibitors (Roche, West
Sussex, UK), 0.6% CHAPs detergent, and 25Uml1 DNAseI. Cells
were lysed by sonication, and the pH of the lysate was adjusted to
7.5. The lysate was clarified by centrifugation at 4100,000 g for
45minutes. The supernatant was loaded onto a HiTrapQ column
followed by a GSTrapHP column (GE Healthcare), both equilibrated
in buffer A. The GSTrapHP column was washed with 10 column
volumes of buffer A and the GST tag was separated from the kazrinA
through on-column digest with PreScission Protease (GE Healthcare)
overnight at 4 1C. The tag-less protein was eluted with buffer A and
further purified using a 26/60 Sephacryl-200 size-exclusion column
(GE Healthcare) equilibrated with buffer A. Fractions containing
kazrinA were pooled, concentrated, and stored at 80 1C.
Generation of pan-kazrin polyclonal antibody
Two rabbits were immunized with full-length human kazrinA using
standard techniques (Covalab, Lyon, France). Antibodies in the
immune serum and non-immune serum were enriched by purifica-
tion of the IgG fraction with proteinA sepharose according to the
manufacturer’s instructions (Thermo Scientific, Hemel Hempstead,
Hertfordshire, UK). The different kazrin antisera, termed 943-074
and 943-009, had very similar properties, although 943-074 bound
kazrin with slightly higher affinity.
Cell culture and transient transfection
Mouse keratinocytes were isolated from 7- to 8-week-old dorsal skin
and cultured as described previously (Silva-Vargas et al., 2005).
Primary human keratinocytes were cultured as described previously
(DiColandrea et al., 2000). Cells were transiently transfected with
two predesigned, inventoried human kazrin siRNAs, s23404 (50-
AGACUUCAUCCGCAACUAU-30) and 261163 (50-CCUGCA
CAACCCUAUUGU-30), two mouse kazrin siRNAs (s231975 50-
AGACUUCAUCCGCAACUAU-30 and s231976 50-GCACCGCAAG
GAGAGUGAA-30) (Ambion, Applied Biosystems, Paisley, UK), pBb-
HA-kazrinA (Sevilla et al., 2008a), or pcDNA3.1/V5/His-kazrin
exons 1–4 using the JetPrime Polyfect transfection reagent (PolyPlus
Transfection, Nottingham, UK) according to the manufacturer’s
instructions. Exons 1–4 (amino acids 1–242) of human kazrinA
(NP_056024.1) were cloned into pcDNA3.1/V5/His using the TOPO
directional cloning kit (Invitrogen, Paisley, UK; catalog no. K4900-
01) and the following primers: 50-CACCATGATGGAAGACAA-
TAAGC-30 (forward); 50-CATGGCCAGCTCGGCCTCC-30 (reverse).
Immunoblotting and immunoprecipitation
Mouse and human primary cultured cells were lysed in 20mM Tris,
pH 7.4, 150mM NaCl, 1mM EGTA, 1mM EDTA and 1% Triton
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X-100. Pan-kazrin polyclonal antibody was crosslinked to ProteinG
Dynabeads (Invitrogen) and used to immunoprecipitate kazrin from
cleared lysates according to the manufacturer’s instructions. Proteins
were eluted in standard sample buffer, separated on 4–12% SDS-
PAGE gels, and transferred onto nitrocellulose membranes in
NuPAGE transfer buffer (Invitrogen) using standard techniques.
Immunoblotting was performed as described previously (Groot
et al., 2004). The following antibodies were used (dilutions
in brackets): rabbit anti-pan-kazrin (1:500), rabbit anti-peptide
antibody to all kazrin isoforms (LS7, 1:500) (Sevilla et al., 2008a),
rabbit anti-kazrin (ProteinTech Group, Manchester, UK; 11572-1-
AP; 1:500), rabbit pre-immune serum (1:500), mouse anti-a-tubulin
(Sigma, Gillingham, Dorset, UK; T6199; 1:2000), and mouse-anti-
glyceraldehyde 3-phosphate dehydrogenase (Millipore, Watford,
UK; MAB374; 1:500). Fluorescently labeled Li-Cor or horseradish
peroxidase-conjugated secondary antibodies were used according to
the manufacturer’s instructions. Blots labeled with Li-Cor secondary
antibodies were imaged using the Li-Cor Odyssey Infrared Imaging
System (Li-Cor Biosciences, Cambridge, UK). Horseradish perox-
idase -conjugated antibodies were detected using standard ECL
reagent (GE Healthcare).
RT-PCR
RNA was extracted from whole skin or cultured cells using the
RNeasy mini kit (Qiagen, Crawley, West Sussex, UK). cDNA was
prepared using a Superscript III First-Strand Synthesis Supermix for
qRT-PCR kit (Invitrogen) according to the manufacturer’s instruc-
tions. Quantitative PCR was performed using designed primers with
the 7900HT Fast-SyberGreen real-time PCR system (Applied
Biosystems). Quantification was based on DDCt calculations, and
all samples were compared against mouse glyceraldehyde 3-
phosphate dehydrogenase as an endogenous control.
Semiquantitative RT-PCR was performed on DNA from cultured
primary mouse keratinocytes with the Fermentas PCR master mix
(Fermentas, Thermo Scientific) according to the manufacturer’s
instructions. The optimal annealing temperature was 55 1C for all the
primers, and 35 reaction cycles were performed. PCR reactions were
run on 3% agarose gels and detected with SYBR Safe (Invitrogen).
Glyceraldehyde 3-phosphate dehydrogenase forward (50-ACCA-
CAGTCCATGCCATCAC-30) and reverse (50-TCCACCACCCTG-
TTGCTGTA-30) primers were used. Mouse kazrin primers are listed
in Supplementary Table S1 online.
Immunohistochemistry and epidermal whole-mount labeling
For paraffin sections, tissues were fixed in formal saline and
embedded in paraffin wax. For frozen sections, tissues were
submerged in OCT compound and frozen on dry ice. Sections—
7mm (paraffin) or 10–12 mm (frozen)—were prepared and collected
onto glass slides.
Tail epidermal whole mounts were prepared essentially as
described previously (Braun et al., 2003). To separate the epidermis
from dermis, skin was incubated at 37 1C in 5mM EDTA in pho-
sphate-buffered saline (PBS) for 1.5 hours (embryonic to P1 skin)
or 4 hours (mice older than P1). The epidermis was fixed in 1%
paraformaldehyde for 1 hour at room temperature before labeling
with the pan-kazrin antiserum, or in 2% paraformaldehyde for
15minutes at room temperature before labeling with all other
antibodies.
Primary antibodies were used at the following dilutions: Alexa-
555-conjugated mouse anti-mouse K14 (1:200), rabbit anti-pan-
kazrin (1:100), protein A–purified rabbit pre-immune serum (1:100),
rabbit anti-periplakin (TD2, 1:100) (DiColandrea et al., 2000), rabbit
anti-desmoplakin (1:200; Santa Cruz Antibodies, Santa Cruz, CA; sc-
33555), mouse anti-desmoplakin (115F, 1:50, gift from DR Garrod,
University of Manchester, Manchester, UK), rabbit anti-peptide
antibody that detects all kazrin isoforms (LS7, 1:50) (Sevilla et al.,
2008a), rabbit anti-Ki67 (1:100; Vector Labs, Peterborough, UK;
clone SP6, VP-RM04), and mouse anti-V5 (1:500; Invitrogen; R960-25).
Species-appropriate secondary antibodies were used to visualize
primary antibodies as described previously (Collins and Watt, 2008).
For Ki67 staining, paraffin sections were subjected to antigen
retrieval using Ventana CC1 solution under standard conditions
(40minutes, 99 1C) (Ventana Molecular Discovery Systems, Tucson,
AZ). Primary antibody was applied for 58minutes at 371C.
Biotinylated secondary antibody was applied for 30minutes at
37 1C and visualized using the Ventana DABMap kit according
to the manufacturer’s instructions. For all other immunohistochem-
istry of paraffin sections, antigen retrieval was performed by boiling
in citrate buffer (pH 6) for 20minutes. Cultured keratinocytes and
frozen sections (thawed briefly) were fixed for 10minutes in 4%
paraformaldehyde at room temperature before labeling, and then
permeabilized for 5minutes with 0.2% Triton X-100 in PBS and
blocked with PBSþ 10% bovine serum and 3% bovine serum
albumin (paraffin sections) or PBSþ 0.5% fish skin gelatin, 5% goat
serum, and 4% BSA (frozen sections) for 1–2 hours at room
temperature. Incubation with primary and secondary antibodies
was performed as described previously (Collins and Watt, 2008).
b-Galactosidase staining
Epidermal whole mounts and frozen sections were fixed in 0.2%
glutaraldehyde in 0.1 M phosphate buffer (pH 7.3) supplemented
with 2mM MgCl (PBS-MgCl2) and 5mM EGTA. Frozen sections were
washed twice in PBS-MgCl2 and incubated in PBS-MgCl2 containing
5mM K3Fe(CN)6, 5mM K4Fe(CN)6, and 1mM X-gal (5-bromo-4-
chloro-3-indolyl b-D-galactopyranoside) overnight at 37 1C to
visualize b-galactosidase activity. Fixed epidermal whole mounts
were stained similarly, except that washing and staining solutions
were supplemented with 0.01% deoxycholate and 0.02% NP-40
(IGEPAL CA-630) to aid permeabilization.
Image capture
Paraffin sections were imaged using a Zeiss Imager.M2 (Carl Zeiss,
Mannheim, Germany). Frozen sections and whole mounts were
imaged using a Leica SP5 confocal microscope. For whole mounts,
images are presented as maximum projections of a series of Z stacks.
Images were optimized for brightness, contrast, and color balance
using Adobe Photoshop.
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